FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas Value to Patient Management and Patient Outcomes

被引：31
作者：
Parikh, Ujas [1 ]
Marcus, Charles [1 ]
Sarangi, Rutuparna [1 ]
Taghipour, Mehdi [1 ]
Subramaniam, Rathan M. [1 ,2 ,3 ]
机构：
[1] Johns Hopkins Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD 21287 USA
[2] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21231 USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA
来源：
PET CLINICS | 2015年 / 10卷 / 03期
关键词：
F-18-FDG PET/CT; Pancreatic cancer; Hepatocellular carcinoma;
D O I：
10.1016/j.cpet.2015.03.001
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
Although F-18-FDG PET/CT has not been shown to offer additional benefit in the initial diagnosis of pancreatic cancer, studies show benefit of F-18-FDG PET/CT in staging, particularly in the detection of distant metastasis, and patient prognosis. Likewise, there is good evidence for F-18-FDG PET and F-18-FDG PET/CT in the staging and prognosis of both cholangiocarcinoma and gallbladder cancer. F-18-FDG PET/CT has shown promise in the staging of liver malignancies by detecting extrahepatic metastasis. There is good evidence supporting the ability of PET/CT in predicting prognosis in patients with HCC. There is evolving evidence for F-18-FDG PET/CTs role in predicting prognosis and survival in patients with CRLM.
引用
收藏
页码：327 / 343
页数：17
相关论文
共 62 条
[31]   18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma: A systematic review and meta-analysis [J].
Lin, Chun-Yi ;
Chen, Jin-Hua ;
Liang, Ji-An ;
Lin, Cheng-Chieh ;
Jeng, Long-Bin ;
Kao, Chia-Hung .
EUROPEAN JOURNAL OF RADIOLOGY, 2012, 81 (09) :2417-2422
[32]  
Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034
[33]   Pancreatic panniculitis [J].
Marsh, RD ;
Hagler, KT ;
Carag, HR ;
Flowers, FP .
EJSO, 2005, 31 (10) :1213-1215
[34]   Evidence-based diagnosis and staging of pancreatic cancer [J].
Michl, P ;
Pauls, S ;
Gress, TM .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2006, 20 (02) :227-251
[35]  
Moon SY, 2013, CLIN NUCL MED, V38, P778, DOI 10.1097/RLU.0b013e31829f8c90
[36]  
Nakamoto Y, 2000, CANCER-AM CANCER SOC, V89, P2547, DOI 10.1002/1097-0142(20001215)89:12<2547::AID-CNCR5>3.0.CO
[37]  
2-V
[38]  
National comprehensive cancer network website, 2014, NCCN GUID VER 1 2014
[39]  
OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO
[40]  
2-E
1234567